Michael Laposata Receives Champion for Innovation Award
Conexiant
November 14, 2025
Michael Laposata, MD, PhD, received the 2025 Champion for Innovation Award from the Association for Molecular Pathology (AMP).
The award recognizes Laposata's contributions to laboratory medicine and his role in a successful legal challenge against an FDA rule on laboratory-developed tests.
The US District Court's decision vacated the FDA rule, preserving diagnostic innovation and patient access to laboratory-developed tests.
Laposata has published over 200 peer-reviewed articles and authored a widely used textbook in laboratory medicine.
The AMP also presented awards to Alexis B. Carter, Dara L. Aisner, MD, PhD, and Lawrence J. Jennings, MD, PhD, for their contributions to clinical practice.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
News Staff
Affiliations:
Specialties:
Areas of Expertise: